Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
9,526,320
-
Share change
-
+5,031,315
-
Total reported value
-
$447,661,000
-
Price per share
-
$47.03
-
Number of holders
-
48
-
Value change
-
+$236,962,427
-
Number of buys
-
36
-
Number of sells
-
5
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2020
As of 30 Sep 2020,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,526,320 shares.
The largest 10 holders included
HILLHOUSE CAPITAL ADVISORS, LTD., Avidity Partners Management LP, Snow Lake Capital (HK) Ltd, ADAGE CAPITAL PARTNERS GP, L.L.C., MANUFACTURERS LIFE INSURANCE COMPANY, THE, Artal Group S.A., Artisan Partners Limited Partnership, ORBIMED ADVISORS LLC, SPHERA FUNDS MANAGEMENT LTD., and MORGAN STANLEY.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.